abstract |
The present invention relates to substituted benzenesulfonamide of formula I as COX-2 inhibiting prodrugs useful in the treatment of inflammation and inflammation-related disorders such as cancer-related pain or toothache. The invention also relates to a pharmaceutical composition comprising a compound of formula I and a preparation thereof. |